ADCNF (Adicon Holdings) EBIT: $14.1 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ADCNF Adicon Holdings Ltd ADCNF
75 GF Score
Price $0.65
GF Value $1.40
! 6 Warning Signs
View Full Analysis

What is Adicon Holdings EBIT?

Adicon Holdings ADCNF 75 EBIT is $14.1 Mil as of Dec. 2025. GuruFocus rates ADCNF with a GF Score™ of 75/100 and a GF Value™ of $1.40. The stock has 6 warning signs investors should review.

Adicon Holdings's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was $4.7 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was $14.1 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Adicon Holdings's annualized ROC % for the quarter that ended in Dec. 2025 was 0.00%. Adicon Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 3.19%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Adicon Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 2.60%.

Adicon Holdings  (OTCPK:ADCNF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Adicon Holdings's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=18.958 * ( 1 - 100% )/( (372.803 + 497.342)/ 2 )
=0/435.0725
=0.00 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=627.787 - 150.378 - ( 104.606 - max(0, 260.46 - 408.193+104.606))
=372.803

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=682.017 - 159.754 - ( 24.921 - max(0, 297.73 - 427.569+24.921))
=497.342

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Adicon Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=9.314/( ( (74.626 + max(171.59, 0)) + (78.076 + max(259.9, 0)) )/ 2 )
=9.314/( ( 246.216 + 337.976 )/ 2 )
=9.314/292.096
=3.19 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(268.508 + 16.138 + 58.357) - (150.378 + 0 + 21.035)
=171.59

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(241.752 + 18.355 + 180.703) - (159.754 + 0 + 21.156)
=259.9

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Adicon Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=14.056/540.787
=2.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adicon Holdings EBIT Related Terms

Adicon Holdings EBIT Historical Data

* Premium members only.

The historical data trend for Adicon Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adicon Holdings EBIT Chart

Adicon Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial 68.07 126.83 61.02 19.82 14.24

Adicon Holdings Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.35 22.22 -2.31 9.40 4.66

ADCNF vs TMO, DHR, IDXX: EBIT Comparison

For the Diagnostics & Research subindustry, Adicon Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Adicon Holdings EV-to-EBIT vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Adicon Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Adicon Holdings's EV-to-EBIT falls into.


ADCNF
75GF Score
Adicon Holdings Ltd ADCNF
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adicon Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $14.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $14.1 Mil mean?
Adicon Holdings (ADCNF) has a EBIT of $14.1 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Adicon Holdings.
Is Adicon Holdings' EBIT too high?
Adicon Holdings' current EBIT is $14.1 Mil. Overall, Adicon Holdings has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Adicon Holdings' EBIT compare to TMO and DHR?
Adicon Holdings' EBIT of $14.1 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Diagnostics & Research company?
A good EBIT depends on the Medical Diagnostics & Research industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Adicon Holdings. Adicon Holdings's current EBIT is $14.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adicon Holdings stock overvalued right now?
Adicon Holdings (ADCNF) has a current EBIT of $14.1 Mil. The stock's GF Value™ is $1.40, compared to a current price of $0.65 — trading 53.6% below its estimated fair value. The current EBIT is $14.1 Mil. Adicon Holdings' overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Adicon Holdings (ADCNF), the current EBIT is $14.1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Adicon Holdings (ADCNF) Overvalued in 2026?

Based on GuruFocus' analysis, Adicon Holdings stock appears to be undervalued. The current stock price of $0.65 is trading 53.6% below its estimated GF Value™ of $1.40.

Key valuation signals for ADCNF:

  • EBIT: $14.1 Mil
  • GF Value™: $1.40 vs. price of $0.65 (53.6% below fair value)
  • GF Score™: 75/100 with 6 warning signs

No single metric tells the full story. See the ADCNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Adicon Holdings Business Description

Other Exchanges 09860:Hong Kong
Address No. 208, Zhenzhong Road, West Lake District, Xihu District, Hangzhou, CHN
Adicon Holdings Ltd is a ICL service provider in China. It offers comprehensive testing services to hospitals and health check centers through an integrated network of self-operated laboratories across China. Its testing services platform includes clinical laboratories, pathology laboratories, reproductive genetics laboratories, gene laboratories, and mass spectrometry laboratories, consisting of over 4,000 medical diagnostic tests, the introduction of over 300 new high-end diagnostic tests.
75GF Score

Get the complete analysis for ADCNF

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.65
Price
$1.40
GF Value